|
|
???tair.name??? >
???browser.page.title.author???
|
"anak o"???jsp.browse.items-by-author.description???
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2020-05-25T07:35:21Z |
RECORD-2: Phase II randomized study of everolimus and bevacizumab versus interferon �\-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma
|
Ravaud A; Barrios C.H; Alekseev B; Tay M.-H; Agarwala S.S; Yalcin S; Chia-Chi Lin; Roman L; Shkolnik M; Anak O; Gogov S; Pelov D; Louveau A.-L; Melichar B. |
| 國家衛生研究院 |
2014-07-02 |
Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib the EVOLVE-1 randomized clinical trial
|
Zhu, AX;Kudo, M;Assenat, E;Cattan, S;Kang, YK;Lim, HY;Poon, RTP;Blanc, JF;Vogel, A;Chen, CL;Dorval, E;Peck-Radosavljevic, M;Santoro, A;Daniele, B;Furuse, J;Jappe, A;Perraud, K;Anak, O;Sellami, DB;Chen, LT |
| 國家衛生研究院 |
2014-01 |
EVOLVE-1: Phase 3 study of everolimus for advanced HCC that progressed during or after sorafenib
|
Zhu, AX;Kudo, M;Assenat, E;Cattan, S;Kang, YK;Lim, HY;Poon, RTP;Blanc, JF;Vogel, A;Chen, CL;Dorval, E;Peck-Radosavljevic, M;Santoro, A;Daniele, B;Furuse, J;Jappe, A;Perraud, K;Anak, O;Sellami, DB;Chen, LT |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
